Advances in Antiviral Drug Design, Volume 3 License:perpetual reagent and solvent selection

reagent and solvent selection

Chapter 3 relates an account of the search for new drugs for the treatment of malaria based on the natural product artemisinin

Appeals to a wide range of engineers

the series features a wide range of reviews by recognized experts on all aspects of plant genetics

* Will enable students and those already in the finance profession to gain an understanding of the basic information and principles of cash flow forecasting

Advances in Antiviral Drug Design, Volume 3 License:perpetual reagent and solvent selectionVolume 3 of Advances in Antiviral Drug Design is keeping up with the recent progress made in the field of antiviral drug research and highlights five specific directions that have opened new avenues for the treatment of virus infections. First, the use of lamivudine (3TC) for the treatment of HIV infections, and its more recent introduction for the treatment of hepatitis B virus (HBV) infections, has heralded the transition of D to L nucleosides in